• GenScript entered a strategic partnership with Tamarind Bio to link AI-driven molecular design with wet-lab validation.
• Deal integrates Tamarind’s platform with GenScript’s synthesis, expression, testing services to speed selection of drug candidates.
• Workflow targets faster experimental data generation, with GenScript citing model-ready results in as little as four days.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GenScript Biotech Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608051215PR_NEWS_USPR_____NY19564) on August 05, 2026, and is solely responsible for the information contained therein.